Announcements
- Globus Medical Receives FDA 510(k) Clearance for ExcelsiusFlex™ and ACTIFY™ 3D Total Knee System
- Globus Medical Schedules Second Quarter Earnings Release and Conference Call
- Globus Medical Reports First Quarter 2024 Results
- Globus Medical Schedules First Quarter Earnings Release and Conference Call
- Globus Medical Reports Fourth Quarter and Full Year 2023 Results
- Globus Medical Schedules Fourth Quarter and Full Year 2023 Earnings Release and Conference Call
- Globus Medical promotes Keith Pfeil to Chief Operating Officer and Chief Financial Officer
- Globus Medical Reports Preliminary Record Fourth Quarter and Full Year Sales Results
- Globus Medical Reports Third Quarter 2023 Results
- Globus Medical Schedules Third Quarter Earnings Release and Conference Call
More ▼
Key statistics
SmartText not available for this item.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | -- |
---|---|
High | 38.94 |
Low | 38.94 |
Bid | -- |
Offer | -- |
Previous close | 38.94 |
Average volume | -- |
---|---|
Shares outstanding | -- |
Free float | -- |
P/E (TTM) | -- |
Market cap | -- |
EPS (TTM) | -- |
Data delayed at least 15 minutes, as of Mar 17 2023 19:49 BST.
More ▼